Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
27.00
-0.15 (-0.55%)
Nov 26, 2025, 4:00 PM EST - Market closed
KMTS Revenue
Kestra Medical Technologies had revenue of $19.37M in the quarter ending July 31, 2025, with 92.67% growth. This brings the company's revenue in the last twelve months to $66.40M, up 85.20% year-over-year. In the fiscal year ending April 30, 2025, Kestra Medical Technologies had annual revenue of $59.82M with 115.05% growth.
Revenue (ttm)
$66.40M
Revenue Growth
+85.20%
P/S Ratio
13.19
Revenue / Employee
$201,224
Employees
330
Market Cap
1.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 59.82M | 32.00M | 115.05% |
| Apr 30, 2024 | 27.81M | 20.18M | 264.53% |
| Apr 30, 2023 | 7.63M | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
KMTS News
- 16 days ago - Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra's ASSURE Device - GlobeNewsWire
- 22 days ago - Kestra Medical Technologies to Present Late-Breaking ACE-PAS Trial Results at AHA 2025, Showcasing Next-Generation Wearable Defibrillator System - GlobeNewsWire
- 4 weeks ago - Kestra Medical Technologies to Present at the Stifel 2025 Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth - GlobeNewsWire
- 2 months ago - Kestra Showcases Cardiac Recovery System Platform at HFSA 2025, Redefining Sudden Cardiac Arrest Risk Management - GlobeNewsWire
- 2 months ago - Kestra Medical Technologies Appoints Dr. Elizabeth Kwo to Board of Directors - GlobeNewsWire
- 2 months ago - Kestra Medical Technologies, Ltd. (KMTS) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results - GlobeNewsWire